Page last updated: 2024-11-03

propranolol and Graves Ophthalmopathy

propranolol has been researched along with Graves Ophthalmopathy in 2 studies

Propranolol: A widely used non-cardioselective beta-adrenergic antagonist. Propranolol has been used for MYOCARDIAL INFARCTION; ARRHYTHMIA; ANGINA PECTORIS; HYPERTENSION; HYPERTHYROIDISM; MIGRAINE; PHEOCHROMOCYTOMA; and ANXIETY but adverse effects instigate replacement by newer drugs.
propranolol : A propanolamine that is propan-2-ol substituted by a propan-2-ylamino group at position 1 and a naphthalen-1-yloxy group at position 3.

Graves Ophthalmopathy: An autoimmune disorder of the EYE, occurring in patients with Graves disease. Subtypes include congestive (inflammation of the orbital connective tissue), myopathic (swelling and dysfunction of the extraocular muscles), and mixed congestive-myopathic ophthalmopathy.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ferreira, C1
Meireles, C1
Marques, O1
Antunes, A1
Lee, S1
Tsirbas, A1
Goldberg, RA1
McCann, JD1

Other Studies

2 other studies available for propranolol and Graves Ophthalmopathy

ArticleYear
Therapeutic challenge of a paediatric case of Graves' disease with severe ophthalmopathy.
    BMJ case reports, 2017, Mar-16, Volume: 2017

    Topics: Antithyroid Agents; Child, Preschool; Female; Glucocorticoids; Goiter; Graves Ophthalmopathy; Humans

2017
Thiazolidinedione induced thyroid associated orbitopathy.
    BMC ophthalmology, 2007, Apr-26, Volume: 7

    Topics: Diplopia; Disease Progression; Drug Therapy, Combination; Exophthalmos; Female; Graves Ophthalmopath

2007